Default Caption Image

The Art of Science: EVIDENT Launches Expanded Global Image of the Year Contest

Октябрь 4, 2022

Now accepting both life and materials science images

WALTHAM, Mass., (Oct. 4, 2022) Evident, a wholly owned subsidiary of Olympus Corporation, announced its fourth Global Image of the Year Scientific Light Microscopy Award is now open for entries through Feb. 28, 2023. Each year, the competition recognizes the best in scientific imaging worldwide. For the first time, the contest welcomes materials science images in addition to life science images to show the versatility of the art of science. Contestants may enter by uploading up to three images, with a description of the equipment used, at Olympus-LifeScience.com/IOTY. Winners will be selected by a jury and announced in summer 2023

Contest Details

The global prize and three regional prizes will be awarded to the scientific images that receive the highest scores. Prizes include an Olympus SZX7 stereo microscope with a DP23 digital camera or X Line™ objectives for the global winner and an Olympus CX23 upright microscope or SZ61 stereo microscope for the regional winners in Asia, Europe and the Americas. An additional prize of an SZ61 stereo microscope will be awarded to the winner of a new dedicated category for materials science and engineering images.

The international jury consists of experts in science and imaging, including Geoff Williams, manager of the Leduc BioImaging Facility at Brown University; Harini Sreenivasappa, microscopy facility manager of the Cell Imaging Center at Drexel University; Rachid Rezgui, research instrumentation scientist at New York University Abu Dhabi; Urs Ziegler, managing director of the Center for Microscopy and Image Analysis at the University of Zurich; Yujie Sun, tenured professor and Boya distinguished professor of Peking University; and Sarah Ellis, head of the Centre for Imaging the Tumour Environment (CITE) at the Olivia Newton-John Cancer Research Institute in Australia.

All entries will be evaluated based on artistic and visual aspects, scientific impact and microscope proficiency.

About the Image of the Year (IOTY) Award

Evident’s IOTY Award began in 2017 as the Image of the Year European Life Science Light Microscopy Award with the aim to celebrate both the artistic and scientific value of microscopy images. Today, the competition stays true to this mission by encouraging people around the world to look at scientific images in a new way, appreciate their beauty, and share images with others.

To learn more about our past award-winning images and the microscope techniques used to capture them, visit Olympus-LifeScience.com/IOTY

About EVIDENT

At Evident, we are guided by the scientific spirit—innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.

Evident Industrial’s solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing and environmental applications. Backed by state-of-the-art technologies, Evident products are widely used for quality control, inspection, and measurement.

Evident Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of microscopes for pathology, hematology, IVF and other clinical applications as well as for research and education.

For more information, visit EvidentScientific.com.

Media Contact:
Hilary Banda
(781) 419-3624
Hilary.Banda@EvidentScientific.com

X Line is a trademark of Evident Corporation or its subsidiaries.

Back to What's New

Not available in your country.
К сожалению, эта страница недоступна в вашей стране.
К сожалению, эта страница недоступна в вашей стране.